Agenda

Section I:Food Regulations and Standards——Session 3:Nutrition Policy

2026-03-14 09:00-12:00 BFA,Dong Yu Grand Ballroom A

2026-03-14 09:00-09:30

National Nutrition Policies

2026-03-14 09:30-10:00

Dietary Guidelines for Chronic Diseases Series

2026-03-14 10:00-10:30

Key Tasks and Future Plans of the National Nutrition Plan for 2026

Zhihong Wang Research Fellow,Deputy Director of,Institute of Nutrition and Health,Chinese Center for Disease Control and Prevention
2026-03-14 11:00-11:30

Agricultural and Food Nutrition Policies and Standards

2026-03-14 11:30-12:00

Roundtable Meeting:Healthy Food High-Quality Development Led by Nutrition Policies and Standards

Moderator:
Li Ning
Research Fellow,Former Director
National Center for Food Safety Risk Assessment (CFSA)
Panelists:
Department of Food Safety Standards,Monitoring and Assessment,National Health Commission
Department of Agricultural Product Quality and Safety Supervision,Ministry of Agriculture and Rural Affairs
Xu Jiao,Research Fellow,National Center for Food Safety Risk Assessment (CFSA)
Yang Yuexin,Research Fellow,President,Chinese Nutrition Society
Liu Aidong,Research Fellow,Director
National Institute for Nutrition and Health,Chinese Center for Disease Control and Prevention (China CDC)
Wang Fengzhong,Research Fellow,Director
Institute of Food and Nutrition Development,Ministry of Agriculture and Rural Affairs

Section II:New Technologies and New Products——Session 2:Efficacy and Evidence-Based Applications of Ergothioneine

2026-03-14 09:00-12:00 Dongyu,Hesheng room(Wanquan Ballroom 1/3)

Moderator:He Tao,Deputy Director,Key Laboratory of Food Nutrition and Health Evaluation Technology,State Administration for Market Regulation
Supported by:Shanghai EGT Synbio Group Co.,Ltd.;GeneIII

2026-03-14 09:00-09:20

Synthetic biology of ergothioneine in edible mushrooms and its anti-aging effects

Jun-Fang Lin Professor,College of Food Science,South China Agricultural University
2026-03-14 09:20-09:40

Dr.Ergo® Ergothioneine:Re-establishing the Value of the 5th-Generation Smart Antioxidants Based on Clinical Evidence

Jason,Shanghai EGT Synbio Group  Co.,Ltd.CEO
2026-03-14 09:40-10:00

Synergistic Inhibition of Acrolein Activity by Ergothioneine and GABA:In Vitro and In Vivo Studies

Lishuang Lv Professor,Nanjing Normal University,Subject leader
2026-03-14 10:00-10:20

Redefining Dietary Supplements with Evidence-Based Science and Human Clinical Evidence

rujun He,Jiangsu Only Three Biotechnology Co.,Ltd.,founding partner
2026-03-14 10:20-10:40

The protective effect of ergothioneine on oxidative damage of nerve cells

YIN SHENG Professor,Beijing Technology and Business University
2026-03-14 10:40-11:00

Section II:New Technologies and New Products——Session 3:New Breakthroughs in HMOs Precision Nutrition and Its Diversified Population Applications

2026-03-14 08:30-11:40 Dongyu,Yiyong room(Wanquan Ballroom 1/3)

Moderators:
Supported by:

2026-03-14 08:30-08:50
2026-03-14 08:50-09:10

Regulatory Effects of HMOs on Glucose and Lipid Metabolism Disorders in Adults

Roy attending doctor,Beijing Friendship Hospital,Capital Medical University
2026-03-14 09:10-09:30
2026-03-14 09:30-09:50

The Potential Application Value of HMOs in the Field of Healthy Aging

SHI LEI Professor,West China Hospital,Sichuan University
2026-03-14 09:50-10:10

Research on the Effect of Human Milk Oligosaccharides on Brain Development

Bailiang Li professor,Northeast Agricultural University,vice director
2026-03-14 10:10-10:30

From the Wisdom of Breast Milk to Clinical Promise:HMOs and Probiotics in Synergy to Protect Preterm Infant Gut Health

Hao Shi,CABIO Biotech (Wuhan) Co.,Ltd.Application R&D Lead,Human Nutrition Business Unit
2026-03-14 10:30-10:50

The Effects of Multiple Human Milk Oligosaccharides and HMO-Based Combinations on Infant/Toddler Health and Neurocognitive Development:Evidence-Based Research and Future Innovation Pathways

Cindy Pan,DSM-Firmenich Greater China Science Affairs Director
2026-03-14 10:50-11:10

Unlocking the Health Code of HMOs:Clinical Research Exploration and Practice by Synaura Bio

Fei Yao,Synaura Biotechnology (Shanghai) Co.,Ltd.Head of Application R&D
2026-03-14 11:10-11:30

Global Trends in HMO Research and Applications

Junai Gan,Novonesis, Human Health Biosolutions Scientific Advisor

Section VI:Probiotics,Prebiotics and Postbiotics——Postbiotics Session

2026-03-14 09:00-11:00 BFA,Dong Yu Grand Ballroom C

2026-03-14 09:00-09:20

A Novel Fermented Oat with Postbiotic Effect:Design Strategies and Scientific Basis

Mary Feng,pepsicoLife Science - Senior Manager
2026-03-14 09:20-09:40

Post LB Postbiotics and the Intestinal Barrier:Current Scientific Evidence and Novel Insights

Chen Yun,Senior Scientist,STA,GC,dsm-firmenich
2026-03-14 09:40-10:00

Postbiotics Along the Gut–Brain Axis:LAC‑Living+ as a Clinically Evidenced Driver of New Growth in Emotional Well‑Being

LI YIRANG,MORINAGA MILK INDUSTRY CO.,LTD.
2026-03-14 10:00-10:20

New Randomized Controlled Trial Findings of Gastric-Derived Lactobacillus johnsonii LJ88 for Gastric Health

WANG HESONG,KAKU Life Science Research Institute General Manager